Inhaled antibiotic shows promise for ventilator lung infections
NCT ID NCT07369336
First seen Jan 27, 2026 · Last updated May 14, 2026 · Updated 17 times
Summary
This study tested whether adding inhaled amikacin to standard treatment helps adults with ventilator-associated pneumonia recover faster. It involved 90 ICU patients on breathing machines. Researchers measured how quickly the infection cleared, how long patients needed the ventilator, and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTILATOR-ASSOCIATED PNEUMONIA (VAP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lahore General Hospital
Lahore, Punjab Province, 54000, Pakistan
Conditions
Explore the condition pages connected to this study.